Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

X4 Pharmaceuticals (XFOR) Accumulated Depreciation (2018 - 2019)

Historic Accumulated Depreciation for X4 Pharmaceuticals (XFOR) over the last 2 years, with Q2 2019 value amounting to $305000.0.

  • X4 Pharmaceuticals' Accumulated Depreciation changed N/A to $305000.0 in Q2 2019 from the same period last year, while for Jun 2019 it was $305000.0, marking a year-over-year change of. This contributed to the annual value of $176000.0 for FY2018, which is N/A changed from last year.
  • As of Q2 2019, X4 Pharmaceuticals' Accumulated Depreciation stood at $305000.0.
  • X4 Pharmaceuticals' Accumulated Depreciation's 5-year high stood at $2.3 million during Q1 2018, with a 5-year trough of $176000.0 in Q4 2018.